Clinical Trials Sponsored by Dompe s.p.a.

Total 672 results

Alfasigma S.p.A.
bioRASI, LLC

Completed

Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea

Papulopustular Rosacea

United States
Giuliani S.p.A
FitBiomics, Inc.

Completed

Efficacy of a Mix of Probiotics in Athletes Performance (GIU-PPA-0420)

Healthy

Italy
Protalix
Chiesi Farmaceutici S.p.A.

Completed

Safety, Efficacy, & PK of PRX-102 in Patients With Fabry Disease Administered Intravenously Every 4 Weeks (BRIGHT)

Fabry Disease

United States, Denmark, Belgium, United Kingdom, Norway, Italy, Czechia
Protalix
Chiesi Farmaceutici S.p.A.

Completed

Extension Study of PRX-102 for up to 60 Months

Fabry Disease

United States, Spain, United Kingdom, Paraguay
Theravance Biopharma
Alfasigma S.p.A.

Completed

The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study (DIGEST)

Gastroparesis
sigma-tau i.f.r. S.p.A.

Completed

A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum Malaria

Malaria,Falciparum

Burkina Faso, Congo, The Democratic Republic of the, Gambia, Mozambique, Tanzania
Philogen S.p.A.
Syneos Health

Completed

A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours

Advanced Solid Tumours

Italy, Germany
Philogen S.p.A.
Eudax S.r.l.

Terminated

Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma

Metastatic Melanoma

Switzerland, Italy, Austria, Germany
Grifols Italia S.p.A
Thrombinoscope

Unknown

Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors (PredicTGA)

Severe Hemophilia A With Inhibitor

Italy
Quince Therapeutics S.p.A.
Biotrial

Not yet recruiting

To Evaluate the Effects of EryDex in Patients With A-T (NEAT)

Ataxia Telangiectasia

Belgium, United States, Denmark, Germany, Italy, Norway, Poland, Spain, United Kingdom
Pharmanutra S.p.a.
Latis S.r.l.

Not yet recruiting

Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Adjuvant Chemotherapy

Breast Cancer | Fatigue

Italy
Protalix
Chiesi Farmaceutici S.p.A.

Completed

Safety and Efficacy of PRX-102 in Patients With Fabry Disease Currently Treated With REPLAGAL® (Agalsidase Alfa)

Fabry Disease

Australia, Netherlands, United Kingdom, Canada, Czechia, Norway, Slovenia
Montecatone Rehabilitation Institute S.p.A.

Withdrawn

Randomized Controlled Study on T-PEP Versus IPV Method for Lower Respiratory Airways Clearance in Tetraplegic Tracheotomized Spinal Cord Injured Patients (T-PEP)

Spinal Cord Injury Cervical

Italy
Montecatone Rehabilitation Institute S.p.A.

Completed

Use of Adhesive Elastic Taping for the Therapy of Medium/Severe Pressure Ulcers in Spinal Cord Injured Patients

Spinal Cord Injuries | Pressure Ulcer

Italy
Montecatone Rehabilitation Institute S.p.A.

Terminated

tDCS in Patients With Disorder of Consciousness Due to Severe Acquired Brain Injury

Brain Injuries | Cognitive Impairment | Consciousness Disorders | Minimally Conscious State | Vegetative State

Italy
sigma-tau i.f.r. S.p.A.

Terminated

Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis

Ulcerative Colitis

Netherlands, Romania, Israel, Czech Republic, Italy, Belgium, Russian Federation, Slovakia
sigma-tau i.f.r. S.p.A.

Completed

A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine

END STAGE RENAL DISEASE

Italy
sigma-tau i.f.r. S.p.A.

Completed

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Malignant Melanoma

France, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
International Biomedical Systems S.p.A.

Unknown

Assessment of the Numen Stent With Evaluation in a Randomized Study (ANSWERS)

Lesion

France
Amryt Pharma
Chiesi Farmaceutici S.p.A.

Not yet recruiting

A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez (FOSteR)

Epidermolysis Bullosa, Junctional | Epidermolysis Bullosa, Dystrophic
Chiesi Farmaceutici S.p.A.
SGS S.A.

Recruiting

Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®

Asthma

Belgium
Chiesi Farmaceutici S.p.A.
ICON plc

Recruiting

Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease (RISE)

Fabry Disease

Japan
CID S.p.A.
Meditrial Europe Ltd.

Not yet recruiting

The Cre8™ BTK Post Market Clinical Follow-up Study

Peripheral Arterial Disease

Italy
Value Outcomes Ltd.
Alfasigma S.p.A.

Recruiting

Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities (SuloPrima)

Chronic Venous Disease | Chronic Insufficiency Venous

Czechia
Kedrion S.p.A.
inVentiv Health Clinical

Terminated

Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients

Hypovolemia

United States
Fondazione Melanoma Onlus
Roche S.p.a

Terminated

Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients (VECODUE)

Melanoma | Melanoma (Skin) | Melanoma Stage

Italy
Federico II University
SOFAR S.p.A.

Completed

Evaluation of a Probiotic (Bifidobacterium in the Treatment of Infantile Colic (IC)

Infantile Colic

Italy
KU Leuven
Chiesi Farmaceutici S.p.A.

Unknown

Evaluate the Effects of Formoterol and Beclomethasone Dipropionate Combination Therapy on Small Airways Function

Emphysema | COPD | Small Airway Disease

Belgium
Chiesi Farmaceutici S.p.A.
Medidata Solutions

Completed

Prospective Study on Asthma Control (PRISMA)

Asthma
Limacorporate S.p.a
Iqvia Pty Ltd

Not yet recruiting

PRIMA EU Retrospective & Prospective

Arthroplasty | Replacement | Shoulder
G. d'Annunzio University
Probiotical S.p.A.

Not yet recruiting

Clinical and Microbiological Aspects of Probiotics in Non-surgical Periodontal Therapy.

Periodontitis | Probiotics | Non Surgical Periodontal Therapy

Italy
University of Bologna
AccYouRate S.p.A.

Recruiting

Evaluation of an Innovative Smart T-shirt Capable to Monitor ECG Signal and Related Parameters Through the Comparison With a Holter ECG and a Smartwatch (Youcare)

Cardiac Arrhythmias

Italy
Quovadis Associazione
Neopharmed Gentili S.p.A.

Active, not recruiting

Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis

Superficial Venous Thrombosis of Leg, Secondary Prevention

Italy
Chiesi Italia

Active, not recruiting

Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control (NEWTON)

Asthma

Italy
Probiotical S.p.A.
University of Florence

Completed

Metabolomic Effects of Probiotics Administration (MAPPINg)

Metabolomic Profile

Italy
Thorne Research Inc.
Indena S.p.A

Terminated

Effects of Quercetin on Metabolic Health

Aging | Lipid Metabolism | Quercetin

United States
Chiesi Farmaceutici S.p.A.
Comac Medical

Completed

CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer

Diabetic Neuropathic Foot Ulcers

Bulgaria
Probiotical S.p.A.
Universita di Verona

Completed

Effects of Probiotics on Mood

Depression, Anxiety

Italy
Philogen S.p.A.
Immatics Biotechnologies GmbH

Terminated

F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma

Merkel Cell Carcinoma

Germany, Austria, Denmark, France, Spain, United Kingdom
UCB Italy s.p.a.

Completed

Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis (SPEED)

Rheumatoid Arthritis

Italy
Chiesi Farmaceutici S.p.A.
Quintiles, Inc.

Completed

Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001

Copd

United Kingdom
PENTA Foundation
Chiesi Farmaceutici S.p.A.

Completed

Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis (NeoMero-2)

Meningitis

United Kingdom
Chiesi Farmaceutici S.p.A.
ICON plc

Not yet recruiting

A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease (FLY)

Fabry Disease
CID S.p.A.
Meditrial Europe Ltd.

Not yet recruiting

The Inperia Advance Post-Market Retrospective Study

Peripheral Arterial Disease

France
CID S.p.A.
Meditrial Europe Ltd.

Not yet recruiting

The Isthmus Logic Post Market Clinical Follow-up Study

Peripheral Arterial Disease

Italy
CID S.p.A.
Meditrial Europe Ltd.

Not yet recruiting

The EasyFlype/EasyHiFlype Post Market Clinical Follow-up Study.

Peripheral Arterial Occlusive Disease | Peripheral Artery Disease

Italy
CID S.p.A.
Meditrial Europe Ltd.

Not yet recruiting

RADIX 2 RENAL STENT Post-Market Retrospective Study (RADIX 2)

Renal Failure | Renal Artery Stenosis

Italy
Chiesi Italia

Completed

Global Burden and Treatment Trajectiories in Italian Patients With Fabry Disease (GROUND)

Fabry Disease

Italy
Pharmanutra S.p.a.
NEA Clinical S.r.l.

Active, not recruiting

CETI-ANKLE: Cetilar®️ in Patients With Ankle Injury or Chronic Trauma to the Ankle

Ankle Injury or Chronic Trauma to the Ankle

Georgia, Italy
Pharmanutra S.p.a.
NEA Clinical S.r.l.

Completed

LIKEST Study: Lipocet® in Adults With Primary Knee Osteoarthritis Grade 3-4

Primary Knee Osteoarthritis Grade 3 - 4

Georgia

Clinical Trials Sponsored by Dompe s.p.a.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations